leader olopatadine hydrochloride ophthalmic solution

Generic: olopatadine hydrochloride ophthalmic solution

Labeler: cardinal health
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name leader olopatadine hydrochloride ophthalmic solution
Generic Name olopatadine hydrochloride ophthalmic solution
Labeler cardinal health
Dosage Form SOLUTION
Routes
OPHTHALMIC
Active Ingredients

olopatadine hydrochloride 1 mg/mL

Manufacturer
CARDINAL HEALTH

Identifiers & Regulatory

Product NDC 70000-0717
Product ID 70000-0717_32bff197-0006-d853-e063-6394a90a8cc2
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA206046
Listing Expiration 2026-12-31
Marketing Start 2025-04-15

Pharmacologic Class

Classes
decreased histamine release [pe] histamine h1 receptor antagonists [moa] histamine-1 receptor antagonist [epc] histamine-1 receptor inhibitor [epc] mast cell stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 700000717
Hyphenated Format 70000-0717

Supplemental Identifiers

RxCUI
1111339
UNII
2XG66W44KF

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name leader olopatadine hydrochloride ophthalmic solution (source: ndc)
Generic Name olopatadine hydrochloride ophthalmic solution (source: ndc)
Application Number ANDA206046 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (70000-0717-1) / 5 mL in 1 BOTTLE
source: ndc

Packages (1)

Ingredients (1)

olopatadine hydrochloride (1 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "32bff197-0006-d853-e063-6394a90a8cc2", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111339"], "spl_set_id": ["d91a3512-b87b-4950-b41d-8d094c0e2c38"], "manufacturer_name": ["CARDINAL HEALTH"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (70000-0717-1)  / 5 mL in 1 BOTTLE", "package_ndc": "70000-0717-1", "marketing_start_date": "20250415"}], "brand_name": "Leader Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "70000-0717_32bff197-0006-d853-e063-6394a90a8cc2", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "70000-0717", "generic_name": "Olopatadine Hydrochloride Ophthalmic Solution", "labeler_name": "CARDINAL HEALTH", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Leader Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA206046", "marketing_category": "ANDA", "marketing_start_date": "20250415", "listing_expiration_date": "20261231"}